- Home
- OPRA vs PSNL Comparison
OPRA vs PSNL Comparison
Compare OPRA & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPRA | PSNL |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | Norway | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OPRA | PSNL |
|---|---|---|
| Price | $17.67 | $16.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $21.50 | $12.20 |
| AVG Volume (30 Days) | 308.7K | ★ 2.4M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $21.29 | $15.34 |
| Revenue Next Year | $15.34 | $41.46 |
| P/E Ratio | $13.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.71 | $4.96 |
| 52 Week High | $21.06 | $18.89 |
Technical Indicators
Market Signals| Indicator | OPRA | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 54.44 |
| Support Level | $17.79 | $15.92 |
| Resistance Level | $19.43 | $16.39 |
| Average True Range (ATR) | 0.50 | 0.45 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 40.56 | 28.92 |
Price Performance
Historical ComparisonAbout OPRA Opera Limited
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.